SAB Biotherapeutics (SABSW) Shares Issued (2020 - 2024)
SAB Biotherapeutics' Shares Issued history spans 5 years, with the latest figure at -$3.0 for Q4 2024.
- For Q4 2024, Shares Issued fell 100.06% year-over-year to -$3.0; the TTM value through Dec 2024 reached $20409.0, up 112.99%, while the annual FY2024 figure was $20409.0, 112.99% up from the prior year.
- Shares Issued reached -$3.0 in Q4 2024 per SABSW's latest filing, down from $20412.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $4.2 million in Q1 2021 to a low of -$4.2 million in Q4 2021.
- Average Shares Issued over 5 years is $10996.8, with a median of $3846.0 recorded in 2023.
- Peak YoY movement for Shares Issued: crashed 16788.0% in 2021, then surged 526300.0% in 2023.
- A 5-year view of Shares Issued shows it stood at $25000.0 in 2020, then plummeted by 16788.0% to -$4.2 million in 2021, then soared by 100.0% to -$1.0 in 2022, then soared by 526300.0% to $5262.0 in 2023, then plummeted by 100.06% to -$3.0 in 2024.
- Per Business Quant, the three most recent readings for SABSW's Shares Issued are -$3.0 (Q4 2024), $20412.0 (Q1 2024), and $5262.0 (Q4 2023).